scholarly journals Percutaneous Embolization of Congenital Portosystemic Venous Fistula in an Infant with Down Syndrome

2013 ◽  
Vol 2013 ◽  
pp. 1-4 ◽  
Author(s):  
Pattaraporn Tanya Chun ◽  
Terrence Chun ◽  
Matthew Files ◽  
Nghia Vo ◽  
Ryan M. McAdams

Congenital intrahepatic portosystemic venous shunts are rare vascular malformations often associated with severe complications. We describe a term male infant with Down syndrome with high output heart failure secondary to a congenital arterial to portal venous fistula that was diagnosed by Doppler ultrasound. Percutaneous embolizations of the left hepatic vein, portal vein, and communicating fistulas were performed without complications, resulting in clinical improvement. A subsequent hepatic ultrasound demonstrated resolution of the pathologic fistulous communication and shunting effects.

Author(s):  
Qiuhua Shen ◽  
Qiuhua Shen ◽  
John B. Hiebert ◽  
Janet D. Pierce

In the U.S., each year, there are more than 500,000 new cases of all types of heart failure. With high output cardiac failure, there is an elevated cardiac output associated with several conditions and diseases, including obesity, chronic anemia, systemic arterio-venous fistula, hypercapnia, mitochondrial dysfunction, and hyperthyroidism. The underlying pathophysiologic mechanisms relate to a reduction in systemic vascular resistance from arterio-venous shunting or peripheral vasodilation. Often there is a decrease in systemic arterial blood pressure and neurohormonal activation leading to heart failure symptoms of dyspnea and fatigue. In a persistent high output state, patients may experience tachycardia, valvular abnormalities, and ventricular dilatation and/or hypertrophy. In this article, there is a review of high output heart failure, including the prevalence, pathophysiology, and common clinical causes of this disease.


2019 ◽  
Vol 12 (11) ◽  
Author(s):  
Pratyaksh K. Srivastava ◽  
Nina Vyas ◽  
Jesse Jones ◽  
Thalia C. Wong ◽  
Kerry Holliman ◽  
...  

2007 ◽  
Vol 149 (12) ◽  
pp. 1243-1247 ◽  
Author(s):  
M. Gallerani ◽  
G. Maida ◽  
B. Boari ◽  
R. Galeotti ◽  
T. Rocca ◽  
...  

2002 ◽  
Vol 11 (5) ◽  
pp. 51-52
Author(s):  
S.S. Damjanovic ◽  
A.N. Neskovic ◽  
M.S. Petakov

2012 ◽  
Vol 2012 (jul09 1) ◽  
pp. bcr2012006289-bcr2012006289 ◽  
Author(s):  
M. I. Mascarenhas ◽  
M. Moniz ◽  
S. Ferreira ◽  
A. Goulao ◽  
R. Barroso

2011 ◽  
pp. P2-705-P2-705
Author(s):  
Jennifer J Miranda ◽  
Marc J Laufgraben ◽  
Simonette Soler ◽  
Athena Poppas ◽  
Geetha Gopalakrishnan

Hypertension ◽  
2021 ◽  
Vol 78 (Suppl_1) ◽  
Author(s):  
Mohammed M Uddin ◽  
Tarec Micho Ulbeh ◽  
Tanveer Mir ◽  
Joseph Sebastian ◽  
Qasim Jehangir ◽  
...  

Background: The literature on the etiologies and complications of high-output heart failure (HOHF) is limited. Objective: To study the causes and complications related to HOHF in the United States (US). Methods: Data from the national readmissions database (NRD) sample that constitutes 49.1% of the stratified sample of all hospitals in the United States, representing more than 95% of the national population were analyzed for hospitalizations with primary diagnosis of HOHF for the years 2017-2018. Etiology associated with HOHF were extracted using ICD-10 codes. Results: A total of 2,107 index hospitalizations (mean age 62.2 ± 19.1) with primary diagnosis of HOHF were recorded in the NRD for the years 2017-2018. The most common causes of HOHF include sepsis 204 (9.7%), leukemia 53 (2.5%), arteriovenous fistula 13 (0.6%), liver cirrhosis 155 (7.4%), Hyperthyroidism 133 (6.3%), thalassemia 23 (1.14%), sickle cell disease 71 (3.35%), morbid obesity 188 (8.95%), COPD 406 (19.3%), myeloproliferative disorders 166 (7.87%). Among the HOHF group, major complications include acute ischemic stroke (42 or 2%), acute kidney injury (593 or 28.1%), hypertensive emergency (74 or 3.5%), atrial fibrillation (409 or 19.4%), ventricular tachycardia/fibrillation (77 or 3.7%), and conduction block (81 or 3.8%) and ST-Elevation myocardial infarction (11 or 0.5%). A total of 83 (3.9%) patients had died during the inpatient hospitalization. Out of the remaining 2,024 patients, a significant portion (62 or 3.1%) required readmission within 30 days. Conclusion: HOHF is an under-reported cardiovascular complication associated with non-cardiovascular disorders. HOHF is associated with significant 30-day readmissions and mortality rates. Proper management of the underlying etiology can prevent the development of HOHF and associated complications. Keywords: cirrhosis; hemodynamics; obesity, leukemia, myeloproliferative disorders, ST-Elevation myocardial infarction (STEMI).


Sign in / Sign up

Export Citation Format

Share Document